<!-- Source: WikiDoc (wikidoc.org) — CC-BY-SA 3.0 -->
<!-- Original: https://www.wikidoc.org/index.php/Diuretic -->
<!-- Downloaded: 2026-02-11 for PostVisit.ai clinical knowledge base -->

# Diuretics

## Definition

Diuretics are drugs that elevate the rate of urine excretion, promoting the removal of sodium and water from the body. They act at different sites along the nephron with varying potency and side effect profiles. Diuretics are essential in managing hypertension, heart failure, and edematous states.

## Classification and Mechanisms

### Loop Diuretics (High-Ceiling Diuretics)

**Mechanism:** Inhibit the Na-K-2Cl symporter in the thick ascending limb of the loop of Henle, preventing sodium, potassium, and chloride reabsorption.

**Potency:** Most potent class, capable of excreting up to 20% of filtered sodium load.

**Agents:** Furosemide (Lasix), bumetanide (Bumex), torsemide (Demadex), ethacrynic acid.

**Key features:**
- Rapid onset (IV furosemide: 5 min; oral: 30-60 min)
- Short duration (4-6 hours for furosemide)
- Torsemide has longer half-life and more reliable oral bioavailability than furosemide
- Also increase calcium and magnesium excretion

### Thiazide Diuretics

**Mechanism:** Inhibit the Na/Cl symporter in the distal convoluted tubule, reducing sodium and chloride reabsorption.

**Agents:** Hydrochlorothiazide (HCTZ), chlorthalidone, indapamide, metolazone.

**Key features:**
- Moderate potency (excrete 5-8% of filtered sodium)
- Longer duration than loop diuretics
- Chlorthalidone preferred over HCTZ for hypertension (longer half-life, better outcome data)
- Antihypertensive effect occurs at doses below maximal diuretic effect
- Decrease calcium excretion (useful in osteoporosis, contraindicated in hypercalcemia)

### Potassium-Sparing Diuretics

**Mechanism:** Preserve potassium while promoting sodium excretion in the cortical collecting duct.

**Two subtypes:**
- **Aldosterone antagonists**: Spironolactone, eplerenone — block mineralocorticoid receptors, preventing sodium channel insertion in collecting duct principal cells
- **ENaC inhibitors**: Amiloride, triamterene — directly block epithelial sodium channels

**Key features:**
- Weak diuretics when used alone
- Usually combined with thiazides or loop diuretics to offset potassium loss
- Spironolactone: GDMT for HFrEF (RALES trial — 30% mortality reduction)
- Eplerenone: More selective, fewer anti-androgenic side effects than spironolactone

### Osmotic Diuretics

**Mechanism:** Pharmacologically inert substances (mannitol, glucose) filtered by glomerulus but not reabsorbed, increasing filtrate osmolarity and retaining water in the tubular lumen.

**Uses:** Acute cerebral edema, acute glaucoma, prevention of acute renal failure.

### Carbonic Anhydrase Inhibitors

**Mechanism:** Inhibit carbonic anhydrase in the proximal tubule, reducing bicarbonate reabsorption and causing alkaline diuresis.

**Agent:** Acetazolamide.

**Uses:** Glaucoma, altitude sickness, metabolic alkalosis correction, epilepsy (adjunct).

## Mechanism Summary

| Class | Nephron Site | Target | Potency |
|-------|-------------|--------|---------|
| Loop | Thick ascending limb | Na-K-2Cl symporter | High (20%) |
| Thiazide | Distal convoluted tubule | Na/Cl symporter | Moderate (5-8%) |
| K+-sparing | Collecting duct | Aldosterone receptor or ENaC | Low (2-3%) |
| Osmotic | Proximal tubule, descending limb | Osmotic gradient | Variable |
| CA inhibitors | Proximal tubule | Carbonic anhydrase | Low |

## Clinical Indications

- **Hypertension**: Thiazides (first-line), loop diuretics for CKD with GFR <30
- **Heart failure**: Loop diuretics (congestion relief), spironolactone/eplerenone (mortality benefit in HFrEF)
- **Edema**: Hepatic cirrhosis (spironolactone + furosemide), nephrotic syndrome, lymphedema
- **Acute pulmonary edema**: IV furosemide
- **Resistant hypertension**: Spironolactone as fourth agent (most effective)
- **Hypercalcemia**: Loop diuretics (increase calcium excretion)
- **Kidney stones**: Thiazides (decrease calcium excretion in calcium stone formers)

## Adverse Effects

### Electrolyte Disturbances

**Hypokalemia** (loop diuretics, thiazides):
- Muscle weakness, cramps, paralysis
- Cardiac arrhythmias (especially with concurrent digoxin)
- Metabolic alkalosis
- Management: Add K+-sparing diuretic, KCl supplementation, monitor levels

**Hyperkalemia** (K+-sparing agents):
- Arrhythmias, muscle cramps, paralysis
- Risk increases with CKD, ACEi/ARB use, K+ supplements
- Monitor K+ closely when combining with ACEi/ARB

**Hyponatremia** (thiazides > loop diuretics):
- CNS dysfunction, confusion, seizures, coma
- More common in elderly, especially with thiazides

**Hypomagnesemia** (loop diuretics, thiazides):
- Can perpetuate hypokalemia (treat Mg2+ first)

### Metabolic Effects
- **Hyperuricemia/gout**: Thiazides and loop diuretics (compete for uric acid secretion)
- **Hyperglycemia**: Thiazides (impaired insulin release)
- **Dyslipidemia**: Thiazides (transient LDL/TG elevation)
- **Hypercalcemia**: Thiazides (reduce calcium excretion)
- **Metabolic alkalosis**: Loop diuretics and thiazides
- **Metabolic acidosis**: CA inhibitors, amiloride, triamterene

### Volume Effects
- Hypovolemia, orthostatic hypotension, dehydration
- Pre-renal azotemia (excessive diuresis)

### Drug-Specific
- **Spironolactone**: Gynecomastia, menstrual irregularities, sexual dysfunction (anti-androgenic)
- **Ethacrynic acid**: Ototoxicity (only non-sulfonamide loop diuretic — use in sulfa allergy)
- **Furosemide**: Ototoxicity (high IV doses), photosensitivity

## Drug Interactions

- **ACEi/ARBs + K+-sparing diuretics**: Hyperkalemia risk (monitor closely)
- **NSAIDs + diuretics**: Reduced diuretic efficacy, increased renal injury risk
- **Lithium + diuretics**: Increased lithium levels (reduced renal clearance)
- **Digoxin + hypokalemia-causing diuretics**: Increased digoxin toxicity risk
- **Aminoglycosides + loop diuretics**: Additive ototoxicity and nephrotoxicity
- **ACEi + NSAID + diuretic ("triple whammy")**: Significantly increased AKI risk

## Monitoring

- Serum electrolytes (Na+, K+, Mg2+, Ca2+) at baseline and regularly
- Renal function (creatinine, BUN)
- Uric acid (if gout history)
- Blood glucose (thiazides)
- Blood pressure and volume status
- Daily weights (heart failure patients)
